Published TCIMAIL newest issue No.201 | Product Document Searching Made Easy by 2D Code! | TCI Chemistry News March 2026 | [Product Highlights] Ionic Liquid and Zinc Compound Used... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 99011-02-6 | ์ ํ๋ฒํธ: I0747
Imiquimod
×
์๋/๋ถ์ ๋ฐฉ๋ฒ: >98.0%(T)(HPLC)
๋์์ด์:
- 1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
- 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline
์ ํ๋ฌธ์:
โข๋ณธ ์ ํ์ ์ฌ๊ณ ๋ ์ผ๋ณธ ๋ณธ์ฌ์ ์ฌ๊ณ ์
๋๋ค. ์ฃผ๋ฌธ์, 5์ผ์์ ์คํ์ค๊น์ง ๋์ฐฉ๋ฉ๋๋ค.
โข๋ณธ๊ฑด์ ์๊ฐ๊ฒฉ์ ํ๊ตญ ๋๋ฆฌ์ ์ ์์ ํ๋งค๊ฐ๊ฒฉ์ ๋๋ค.์์ธํ ์ ๋ณด๊ฐ ํ์ํ์๋ฉด ์ฐ๋ฝํด ์ฃผ์ญ์์ค.( SEJIN CI Co., Ltd. (ํ๊ตญ์ด๋๋ฆฌ์ ) ์ ํ : 02-2655-2480 ์ด๋ฉ์ผ : sales@sejinci.co.kr)
โข๋ณด๊ด ์กฐ๊ฑด์ ์๊ณ ์์ด ๋ณ๊ฒฝ ๋ ์ ์์ต๋๋ค. ์ ํ ๋ณด๊ด ์กฐ๊ฑด์ ์ต์ ์๋ฃ๋ ํํ์ด์ง์ ๊ธฐ์ฌ๋์ด ์์ผ๋ ์ํด ๋ถํ๋๋ฆฝ๋๋ค.
โข๋ณธ๊ฑด์ ์๊ฐ๊ฒฉ์ ํ๊ตญ ๋๋ฆฌ์ ์ ์์ ํ๋งค๊ฐ๊ฒฉ์ ๋๋ค.์์ธํ ์ ๋ณด๊ฐ ํ์ํ์๋ฉด ์ฐ๋ฝํด ์ฃผ์ญ์์ค.( SEJIN CI Co., Ltd. (ํ๊ตญ์ด๋๋ฆฌ์ ) ์ ํ : 02-2655-2480 ์ด๋ฉ์ผ : sales@sejinci.co.kr)
โข๋ณด๊ด ์กฐ๊ฑด์ ์๊ณ ์์ด ๋ณ๊ฒฝ ๋ ์ ์์ต๋๋ค. ์ ํ ๋ณด๊ด ์กฐ๊ฑด์ ์ต์ ์๋ฃ๋ ํํ์ด์ง์ ๊ธฐ์ฌ๋์ด ์์ผ๋ ์ํด ๋ถํ๋๋ฆฝ๋๋ค.
์ ํ๋ณด์ถฉ์ ๋ณด:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| ์ ํ๋ฒํธ | I0747 |
Purity/Analysis Method 
|
>98.0%(T)(HPLC) |
| M.F. / M.W. | C__1__4H__1__6N__4 = 240.31 |
| ๋ฌผ๋ฆฌ์ ์ํ (20 โ) | Solid |
| ๋ณด๊ด ์กฐ๊ฑด
|
Room Temperature (Recommended in a cool and dark place, <15ยฐC) |
| ์ฉ๊ธฐ
|
100MG-Glass Bottle with Plastic Insert (์ด๋ฏธ์ง ๋ณด๊ธฐ), 1G-Glass Bottle with Plastic Insert (์ด๋ฏธ์ง ๋ณด๊ธฐ) |
| CAS RN | 99011-02-6 |
| Reaxys-RN | 7710060 |
| PubChem Substance ID | 87561300 |
| Merck Index (14) | 4922 |
| MDL ๋ฒํธ | MFCD00866946 |
๊ท๊ฒฉํ
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
๋ฌผ์ฑ์น(์ฐธ๊ณ ์น)
| mp | 294 ยฐC |
| Maximum Wavelength | 245 nm (H__2O/MeOH) |
GHS
| ํฝํ ๊ทธ๋จ |
|
| ์ ํธ ์๋ | Danger |
| ์ํ๋ฌผ ๋ฐ ์ ํด ๋ฑ๋ก | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| ์ฃผ์ ์ฌํญ | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
๋ฒ๊ท ์ ๋ณด
| RTECS # | NJ5903450 |
์ด์ก ์ ๋ณด
| UN ๋ฒํธ | UN2811 |
| ๋ฑ๊ธ | 6.1 |
| ํฌ์ฅ ๊ทธ๋ฃน | III |
| HS ๋ฒํธ* | 2933.99-000 |
Application
Imiquimod: A Toll-Like Receptor (TLR) 7 Agonist and a Potent Immune Activator
Imiquimod is reported as a Toll-like receptor (TLR) 7 agonist and a potent immune activator. Imiquimod activates innate immune cells to produce interferon-α (IFN-α) and other cytokines both in vitro and in vivo. This immune-based mechanism provides activity against a number of viruses. In addition, it is also used for a reagent for inflammation and immunity disorder models. (The product is for research purpose only.)
References
- Imiquimod applied topically: a novel immune response modifier and new class of drug
- Imiquimod and resiquimod as novel immunomodulators
- Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
- Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
PubMed Literature
๋ฌธ์
์ ํ๊ธฐ์ฌ
์ ํ๋ฌธ์ (๋ถ์ ์ฐจํธ๋ฅผ ์ ๊ณตํ์ง ๋ชปํ ์๋ ์์ผ๋ ์ํด ๋ฐ๋๋๋ค.)
SDS
์ธ์ด๋ฅผ ์ ํํ์ญ์์ค.
์์ฒญํ SDS๋ฅผ ์ฌ์ฉํ ์ ์์ต๋๋ค.
๋ฒ๊ฑฐ๋กญ๊ฒ ํด๋๋ ค ์ฃ์กํ์ง๋ง ์ด ์์ ๋ณด๋ค ๋ฌธ์ ํด์ฃผ์ญ์์ค.
๊ท๊ฒฉํ
์ํ์ฑ์ ์๏ผ ๊ฐ์ข ์ฆ๋ช ์
๋กฏํธ ๋ฒํธ๋ฅผ ์
๋ ฅํ์ญ์์ค.
์๋ชป๋ ๋กํธ ๋ฒํธ๊ฐ ์
๋ ฅ๋์์ต๋๋ค.
์ํ ์ํ์ฑ์ ์
์ํ์ฑ์ ์ ์ํ์ ๋ค์ด๋ก๋ํ ์ ์์ต๋๋ค. ์ํ์ ๋ฐ๋์ ์ต์ ๋กํธ์ ๊ฒฐ๊ณผ๋ฅผ ๋ํ๋ด๋ ๊ฒ์ ์๋๋๋ค.
๋ณธ ์ ํ์ ์ํ์ํ์ฑ์ ์๋ ํ์ฌ ์ค๋น๋์ด ์์ง ์์ต๋๋ค.
๋ถ์ ์ฐจํธ
๋กฏํธ ๋ฒํธ๋ฅผ ์
๋ ฅํ์ญ์์ค.
์๋ชป๋ ๋กํธ ๋ฒํธ๊ฐ ์
๋ ฅ๋์์ต๋๋ค.
์ฃ์กํฉ๋๋ค๋ง ์ฐพ์ผ์๋ ๋ถ์์ฐจํธ๋ ์์ต๋๋ค.